Showing results (411-420 of 460) with videos related to

Sort By:
Pageof 46
The Journal of Infectious Diseases|December 23, 1999
Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapyT Schacker, S Little, E Connick, et al.
JAMA|July 14, 1989
Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study GroupR J Whitley, C G Cobbs, C A Alford, et al.
The Journal of Infectious Diseases|July 1, 1988
Changing presentation of herpes simplex virus infection in neonatesR J Whitley, L Corey, A Arvin, et al.
Circulation|November 9, 2000
Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults : the Cardiovascular Health StudyD S Siscovick, S M Schwartz, L Corey, et al.
AIDS Research and Human Retroviruses|December 1, 1994
Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials NetworkM C Keefer, B S Graham, R B Belshe, et al.
Eplasty|March 13, 2026
Replacing Bacitracin With Vancomycin in Adams Triple Antibiotic Solution for Irrigation in Breast Implant Reconstruction: A Retrospective Review of 277 ReconstructionsQuinton L Carr, Colton H Connor, Ryan Cantrell, et al.
Transplantation Proceedings|January 21, 2025
Performance of Glomerular Filtration Rate Estimating Equations in Kidney Transplant Recipients of Various Races: A Retrospective Cohort StudyPooja Budhiraja, Richard Butterfield, Musab Hommos, et al.
The Journal of Infectious Diseases|November 14, 1997
Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trialS E Straus, A Wald, R G Kost, et al.
The Journal of Infectious Diseases|April 25, 2001
Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDSM M Berrey, T Schacker, A C Collier, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1986
A placebo-controlled trial of topical 8% arildone cream early in recurrent genital herpesJ M Douglas, F N Judson, M J Levin, et al.
Pageof 46